ADARx 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ADX-324 / ADARx
STOP-HAE, NCT06960213: A Phase 3 Study of ADX-324 in HAE

Not yet recruiting
3
90
NA
ADX-324, siRNA, Placebo, Saline
ADARx Pharmaceuticals, Inc.
Hereditary Angioedema
12/26
12/26
NCT05691361: Safety, Tolerability, PK, PD of ADX-324 in Healthy Volunteers and Hereditary Angioedema Patients

Recruiting
1/2
53
RoW
ADX-324, siRNA, Placebo, Saline
ADARx Pharmaceuticals, Inc., Avance Clinical Pty Ltd.
Hereditary Angioedema
07/25
01/26
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ADX-324 / ADARx
STOP-HAE, NCT06960213: A Phase 3 Study of ADX-324 in HAE

Not yet recruiting
3
90
NA
ADX-324, siRNA, Placebo, Saline
ADARx Pharmaceuticals, Inc.
Hereditary Angioedema
12/26
12/26
NCT05691361: Safety, Tolerability, PK, PD of ADX-324 in Healthy Volunteers and Hereditary Angioedema Patients

Recruiting
1/2
53
RoW
ADX-324, siRNA, Placebo, Saline
ADARx Pharmaceuticals, Inc., Avance Clinical Pty Ltd.
Hereditary Angioedema
07/25
01/26

Download Options